See also this year's filing and all EDGAR filings for this company.
PDF Report 0001589150_2019_Regen_BioPharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001589150')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001589150, Regen BioPharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 42,771 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 166,247 |
| 4 | LiabilitiesCurrent | 8,673,511 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 657,178 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 743,755 |
| 9 | ResearchAndDevelopmentExpense | 374,436 |
| 10 | remainder_Expenses | 407,592 |
| 11 | remainder_Revenues | 100,000 |
| 12 | remainder_NetIncome | -3,289,417 |
| 13 | remainder_ComprehensiveNetIncome | -35,052 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 209,018 |
| 1 | Liabilities | 9,330,689 |
| 2 | Expenses | 1,525,783 |
| 3 | Revenues | 100,000 |
| 4 | StockholdersEquity | -9,121,671 |
| 5 | NetIncome | -4,715,200 |
| 6 | ComprehensiveNetIncome | -4,732,726 |
| 7 | BaseVar | 7,244,980 |
| 8 | EconomicCapitalRatio | -4.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
